Variant report

Variant	nsv1050912
Chromosome Location	chr12:371410-402148
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr12:373538-373815	K562	blood:	n/a	n/a
2	BATF	chr12:382502-382775	GM12878	blood:	n/a	n/a
3	BCL3	chr12:377133-378098	A549	lung:	n/a	n/a
4	BRCA1	chr12:388853-388959	Hela-S3	cervix:	n/a	n/a
5	CEBPB	chr12:400603-400855	A549	lung:	n/a	chr12:400672-400683
6	CEBPB	chr12:400511-400815	IMR90	lung:	n/a	chr12:400672-400683
7	CEBPB	chr12:373496-373744	K562	blood:	n/a	n/a
8	CEBPB	chr12:400492-400851	Hela-S3	cervix:	n/a	chr12:400672-400683
9	CEBPB	chr12:400521-400792	HepG2	liver:	n/a	chr12:400672-400683
10	CEBPB	chr12:400574-400774	K562	blood:	n/a	chr12:400672-400683
11	CTCF	chr12:399220-399370	HepG2	liver:	n/a	n/a
12	CTCF	chr12:376720-376870	SAEC	small airway:	n/a	n/a
13	CTCF	chr12:391102-391136	Spleen_OC	spleen:	n/a	n/a
14	CTCF	chr12:391149-391201	Lung_OC	lung:	n/a	n/a
15	CTCF	chr12:382320-382470	HCPEpiC	choroid plexus:	n/a	n/a
16	CUX1	chr12:373538-373615	K562	blood:	n/a	n/a
17	E2F4	chr12:392202-392344	MCF10A-Er-Src	breast:	n/a	n/a
18	EP300	chr12:373428-374103	K562	blood:	n/a	n/a
19	EP300	chr12:400561-400810	Hela-S3	cervix:	n/a	n/a
20	ESR1	chr12:372002-372346	ECC-1	luminal epithelium:	n/a	n/a
21	FAM48A	chr12:393132-393260	GM12878	blood:	n/a	n/a
22	FOS	chr12:401448-401703	MCF10A-Er-Src	breast:	n/a	chr12:401589-401599 chr12:401589-401599 chr12:401590-401598 chr12:401589-401599 chr12:401589-401599
23	FOS	chr12:401447-401647	MCF10A-Er-Src	breast:	n/a	chr12:401589-401599 chr12:401589-401599 chr12:401590-401598 chr12:401589-401599 chr12:401589-401599
24	FOS	chr12:372922-373109	MCF10A-Er-Src	breast:	n/a	chr12:372990-373000
25	FOS	chr12:397831-398226	MCF10A-Er-Src	breast:	n/a	n/a
26	FOS	chr12:397836-398206	MCF10A-Er-Src	breast:	n/a	n/a
27	FOS	chr12:397873-398211	MCF10A-Er-Src	breast:	n/a	n/a
28	FOS	chr12:401448-401714	MCF10A-Er-Src	breast:	n/a	chr12:401589-401599 chr12:401589-401599 chr12:401590-401598 chr12:401589-401599 chr12:401589-401599
29	FOS	chr12:397897-398164	MCF10A-Er-Src	breast:	n/a	n/a
30	FOXA1	chr12:387844-388107	HepG2	liver:	n/a	n/a
31	FOXA1	chr12:383279-383584	T-47D	breast:	n/a	chr12:383516-383528
32	FOXA1	chr12:382698-383077	T-47D	breast:	n/a	chr12:382894-382909 chr12:382860-382875
33	FOXA1	chr12:382677-382977	T-47D	breast:	n/a	chr12:382894-382909 chr12:382860-382875
34	GATA1	chr12:373339-373784	PBDE	blood:	n/a	n/a
35	GATA1	chr12:373161-373880	K562	blood:	n/a	n/a
36	GATA2	chr12:373545-373749	SH-SY5Y	brain:	n/a	n/a
37	HNF4A	chr12:380373-380573	HepG2	liver:	n/a	chr12:380519-380534 chr12:380520-380534 chr12:380519-380534 chr12:380518-380536 chr12:380519-380534 chr12:380521-380533 chr12:380520-380533 chr12:380519-380534 chr12:380519-380534 chr12:380521-380533
38	IRF1	chr12:373834-373835	K562	blood:	n/a	n/a
39	JUN	chr12:400574-400722	HepG2	liver:	n/a	chr12:400673-400686
40	JUND	chr12:372969-373030	K562	blood:	n/a	chr12:372990-373000
41	JUND	chr12:400510-400750	HepG2	liver:	n/a	n/a
42	JUND	chr12:376215-376332	HepG2	liver:	n/a	n/a
43	JUND	chr12:372048-372141	K562	blood:	n/a	n/a
44	JUND	chr12:373451-373805	K562	blood:	n/a	n/a
45	MAFF	chr12:373589-373727	K562	blood:	n/a	n/a
46	MAFK	chr12:373576-373776	HepG2	liver:	n/a	n/a
47	MAFK	chr12:373506-373800	K562	blood:	n/a	n/a
48	MAFK	chr12:390449-390555	H1-hESC	embryonic stem cell:	n/a	n/a
49	MAFK	chr12:382695-382869	HepG2	liver:	n/a	n/a
50	MAX	chr12:373552-373712	K562	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:372139-372189	Caco-2	colon:	n/a
2	chr12:372139-372189	Caco-2	colon:	n/a
3	chr12:372790-372840	SKMC	muscle:	n/a
4	chr12:392537-392587	AG04449	skin:	fetal
5	chr12:378771-378821	Caco-2	colon:	n/a
6	chr12:378771-378821	SK-N-SH	brain:	n/a
7	chr12:371916-371966	H1-hESC	embryonic stem cell:	embryo
8	chr12:371916-371966	HUVEC	blood vessel:	n/a
9	chr12:372049-372099	HRPEpiC	eye:	n/a
10	chr12:371950-372000	SKMC	muscle:	n/a
11	chr12:372246-372296	PFSK-1	brain:	n/a
12	chr12:372191-372241	SKMC	muscle:	n/a
13	chr12:372790-372840	K562	blood:	n/a
14	chr12:371916-371966	GM06990	blood:	n/a
15	chr12:392537-392587	HNPCEpiC	eye:	n/a
16	chr12:392537-392587	K562	blood:	n/a
17	chr12:392537-392587	PrEC	prostate:	n/a
18	chr12:372246-372296	HMEC	breast:	n/a
19	chr12:371916-371966	LNCaP	prostate:	n/a
20	chr12:372139-372189	AG09319	gingival:	n/a
21	chr12:392537-392587	IMR90	lung:	fetal
22	chr12:372049-372099	HPAEpiC	pulmonary alveolar:	n/a
23	chr12:378771-378821	BE2_C	brain:	n/a
24	chr12:378771-378821	HIPEpiC	eye:	n/a
25	chr12:372049-372099	HCM	heart:	n/a
26	chr12:392537-392587	ECC-1	luminal epithelium:	n/a
27	chr12:372049-372099	RPTEC	kidney:	n/a
28	chr12:372259-372309	Hepatocyte	liver:	n/a
29	chr12:371916-371966	NT2-D1	testis:	n/a
30	chr12:372049-372099	CMK	blood:	n/a
31	chr12:378771-378821	HCPEpiC	choroid plexus:	n/a
32	chr12:372790-372840	PrEC	prostate:	n/a
33	chr12:372191-372241	GM19239	blood:	n/a
34	chr12:372139-372189	BJ	skin:	n/a
35	chr12:372191-372241	HAEpiC	amniotic membrane:	n/a
36	chr12:372246-372296	BE2_C	brain:	n/a
37	chr12:372191-372241	Caco-2	colon:	n/a
38	chr12:372790-372840	BE2_C	brain:	n/a
39	chr12:372049-372099	HCF	heart:	n/a
40	chr12:378771-378821	GM12878	blood:	n/a
41	chr12:371950-372000	HCM	heart:	n/a
42	chr12:372049-372099	PFSK-1	brain:	n/a
43	chr12:372049-372099	Jurkat	blood:	n/a
44	chr12:372191-372241	SK-N-SH_RA	brain:	n/a
45	chr12:372790-372840	HPAEpiC	pulmonary alveolar:	n/a
46	chr12:371950-372000	AG04450	lung:	fetal
47	chr12:371916-371966	A549	lung:	n/a
48	chr12:378771-378821	PANC-1	pancreas:	n/a
49	chr12:372139-372189	MCF10A-Er-Src	breast:	n/a
50	chr12:372191-372241	HRE	kidney:	n/a

No.	Distal block	Cell Line	Cell type
1	chr12:381899..385111-chr12:386819..388918,3	K562	blood:
2	chr12:391396..393092-chr12:395064..396850,2	K562	blood:
3	chr12:378409..380462-chr12:383368..386178,2	MCF-7	breast:
4	chr12:371815..374343-chr12:375834..377592,4	K562	blood:
5	chr12:369816..372336-chr12:398324..400743,2	K562	blood:
6	chr12:381899..385111-chr12:386819..388918,3	K562	blood:
7	chr12:391396..394249-chr12:395350..397810,2	K562	blood:
8	chr12:391396..393092-chr12:395064..396850,2	K562	blood:
9	chr12:371632..373367-chr12:383696..385601,2	MCF-7	breast:
10	chr12:391396..394249-chr12:395350..397810,2	K562	blood:
11	chr12:378409..380462-chr12:383368..386178,2	MCF-7	breast:
12	chr12:303209..305233-chr12:388816..390804,2	K562	blood:
13	chr12:371815..373339-chr12:375834..377443,2	K562	blood:
14	chr12:381899..384416-chr12:386819..388918,2	K562	blood:
15	chr12:381899..384416-chr12:386819..388918,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KDM5A-1	chr12:383120-386289	ENSG00000261799.1

Variant related genes	Relation type
KDM5A	TF binding region
ENSG00000255746	TF binding region
SLC6A13	TF binding region
ENSG00000261799	TF binding region
KDM5A	CpG island
ENSG00000255746	CpG island
SLC6A13	CpG island
ENSG00000261799	CpG island
ENSG00000010379	chromatin interactions

Extended variants
information (count: 1233 )
Associated
traits (count: 84 )

Variant overlapped rSNPs/rCNVs (count:1233 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs527118	chr12:371410-371411	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs187628828	chr12:371423-371424	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs533655332	chr12:371428-371429	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs114965123	chr12:371439-371440	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs573761074	chr12:371446-371447	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs578107114	chr12:371447-371448	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs556192117	chr12:371630-371631	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs578028524	chr12:371663-371664	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs544620624	chr12:371673-371674	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs75028535	chr12:371680-371681	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs145313203	chr12:371707-371708	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs191943869	chr12:371713-371714	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs201520083	chr12:371731-371732	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs540388850	chr12:371745-371746	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs524468	chr12:371786-371787	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
16	rs563628461	chr12:371790-371791	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs529326143	chr12:371830-371831	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs550610245	chr12:371840-371841	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs368082174	chr12:371852-371853	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs533467329	chr12:371935-371936	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs552006160	chr12:372035-372036	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs566965623	chr12:372088-372089	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs534436193	chr12:372097-372098	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
24	rs555971755	chr12:372124-372125	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs567414137	chr12:372145-372146	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
26	rs537929364	chr12:372175-372176	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
27	rs556204538	chr12:372189-372190	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
28	rs541407624	chr12:372192-372193	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
29	rs533403394	chr12:372196-372197	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs577664333	chr12:372204-372205	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
31	rs548915874	chr12:372226-372227	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
32	rs73604849	chr12:372285-372286	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs572232255	chr12:372325-372326	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs542836189	chr12:372344-372345	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs528546257	chr12:372351-372352	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs560746793	chr12:372358-372359	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs183667999	chr12:372371-372372	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs1548904	chr12:372382-372383	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
39	rs151010095	chr12:372403-372404	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs183854313	chr12:372410-372411	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs140851785	chr12:372414-372415	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs797765	chr12:372438-372439	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
43	rs568493118	chr12:372495-372496	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs560867326	chr12:372526-372527	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs76907414	chr12:372616-372617	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs369996227	chr12:372655-372656	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs549637877	chr12:372703-372704	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs567819117	chr12:372757-372758	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs34328511	chr12:372770-372771	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs16928976	chr12:372773-372774	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:84)

Disease	PMID	Source
Cancer	20164920	CNVD
Myelofibrosis	22110671	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Glaucoma	21310917	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Squamous cell cancer	19607727	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Mental retardation	17847001	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
abnormal development	18461090	CNVD
Ovarian cancer	20844748	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
small cell lung cancer	20016488	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Autism	22495309	CNVD
Ovarian cancer	21720365	CNVD
Myelodysplastic syndrome	21251322	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Cancer	20164919	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Glioblastoma multiforme	22291905	CNVD

Chromatin state (count:761 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:371200-371600	Enhancers	HSMMtube	muscle
2	chr12:371200-372000	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
3	chr12:371200-372000	Flanking Active TSS	Fetal Kidney	kidney
4	chr12:371200-372400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr12:371200-372400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
6	chr12:371200-372400	Enhancers	Fetal Muscle Leg	muscle
7	chr12:371200-372400	Enhancers	HepG2	liver
8	chr12:371200-373200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
9	chr12:371400-372200	Weak transcription	Thymus	Thymus
10	chr12:371400-372400	Bivalent Enhancer	Fetal Lung	lung
11	chr12:371400-373400	Enhancers	K562	blood
12	chr12:371600-372000	Enhancers	ES-I3 Cell Line	embryonic stem cell
13	chr12:371600-372000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr12:371600-372000	Enhancers	iPS-18 Cell Line	embryonic stem cell
15	chr12:371600-372000	Flanking Active TSS	HSMMtube	muscle
16	chr12:371600-372400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
17	chr12:371600-372600	Enhancers	Fetal Heart	heart
18	chr12:371600-373600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
19	chr12:371600-373600	Enhancers	HSMM	muscle
20	chr12:371800-372000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
21	chr12:371800-372200	Enhancers	Breast Myoepithelial Primary Cells	Breast
22	chr12:371800-372400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
23	chr12:371800-372600	Enhancers	Placenta	Placenta
24	chr12:371800-373000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
25	chr12:371800-373400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
26	chr12:371800-373400	Enhancers	NH-A	brain
27	chr12:371800-373600	Weak transcription	Primary T helper naive cells from peripheral blood	blood
28	chr12:371800-376800	Weak transcription	Brain Anterior Caudate	brain
29	chr12:372000-372200	Enhancers	Fetal Kidney	kidney
30	chr12:372000-372400	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
31	chr12:372000-372400	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr12:372000-372800	Enhancers	HSMMtube	muscle
33	chr12:372000-373400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
34	chr12:372000-376200	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
35	chr12:372000-376400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
36	chr12:372000-379200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
37	chr12:372200-372400	Enhancers	HUES6 Cell Line	embryonic stem cell
38	chr12:372200-372400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
39	chr12:372200-372400	Flanking Active TSS	Fetal Kidney	kidney
40	chr12:372200-372400	Bivalent Enhancer	Fetal Stomach	stomach
41	chr12:372200-372400	Enhancers	Lung	lung
42	chr12:372200-372400	Enhancers	Thymus	Thymus
43	chr12:372200-372400	Bivalent Enhancer	NHEK	skin
44	chr12:372200-373000	Enhancers	Osteobl	bone
45	chr12:372200-373200	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
46	chr12:372200-373200	Enhancers	Muscle Satellite Cultured Cells	--
47	chr12:372400-372600	Enhancers	Fetal Kidney	kidney
48	chr12:372400-372800	Weak transcription	Lung	lung
49	chr12:372400-373000	Weak transcription	Thymus	Thymus
50	chr12:372400-377000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links